OMX30 1 575 -0,3%  OMXH25 4 202 -0,2%  Bitcoin 7 745,19 4,6%  Dow 25 058 0,0%  Nas 7 350 0,0%  EUR 10,3808 0,0%  USD 8,8420 -0,1%  Olja 73,1 0,1%  Guld 1 231 -0,3% 

Ipsen Aktie

142,70EUR -0,55EUR -0,38%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Fundamentala nyckeltal för Ipsen

2017 2018e 2019e 2020e 2021e
Utdelning 0,87 1,10 1,23 1,34 0,85
Direktavkastning (i %) 0,86 0,77 0,86 0,94 0,60
PE-tal 23,27 26,70 21,88 18,42 15,45
Resultat/aktie 4,36 5,32 6,50 7,72 9,20

Nyheter om Ipsen

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Ipsen

ytterligare analyser

Ipsen Peer Group

Ipsen 142,70
-0,4%
pagehit

Lägg till instrument

Vad tycker du?

Profil Ipsentill bolagsprofilen

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults and children; and Fortrans, a colon cleansing solution indicated for patients in preparation for endoscopic, radiological examinations or colonic surgery. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Realtidskurs Ipsen

Bid 142,60 EUR Ask 143,10 EUR
Kurstid 09:25 Börsen STU

Aktiekurs Ipsen i EURPUSH CHART

Kurs 142,70 EUR -0,55 -0,38 %
Kurstid 09:28:38
Datum 23.07.2018
Öppning 143,00
Gårdagen 143,25
Dagshögsta 143,50
Dagslägsta 142,50
52 v. högsta 145,50
52 v. lägsta 97,24
52 v. perf.
Volym (Antal) 5 030
Börsvärde (SEK) 123,73 Mrd
Börsen
Kurs för 142,70 EUR från börsen Paris motsvarar med aktuell växelkurssentspricht EUR/SEK en kurs på 1 481,34 SEK.

Till aktien Ipsen

Ticker
ISIN FR0010259150
Index CAC MID 60, SBF 120

Ipsen Nyckeltal

Börsvärde i SEK 123,73 Mrd
Free float %
Antal aktier mio. 83,79
Cashflow/aktie i lokal valuta 4,93
Bokvärde/aktie i lokal valuta 18,38
60 dagar vola 19,88
PBV

Ipsen Historiska kurser

2018-07-20 143,25 71 803
2018-07-19 142,15 88 997
2018-07-18 142,25 125 166
2018-07-17 143,80 76 856
2018-07-16 142,25 77 727